Roblox’s Q3: Revenue Up, but Bookings Down—The Cracks in the Growth Story

Posted on by Elim

RBLX   Daily · data to 2026-10-29 close · 10 SMA 20 SMA 50 SMA 150 SMA RS vs Nasdaq
Frozen at publication – this chart does not move. Open live chart on TradingView →

Roblox Q3: revenue up but bookings down, paying users fell, and Q4 free cash flow turns negative. Management dodged tough questions, blaming macro while burning cash on AI and safety. With the stock down 17%, is the growth story over? Read the full analysis.

Inside the Full Analysis

  • 🔒Roblox’s Q3: Revenue Up, But Bookings Down—The Cracks in the Growth Story
  • 🔒The Vanishing Paying Users and the Cash Burn Nobody Wants to Talk About
  • 🔒From “Healthy Growth” to “Challenging Environment”: The Script Cracks
  • 🔒Three Questions Analysts Should Have Asked (But Didn’t Get Straight Answers To)
  • 🔒Blame the Macro? Not So Fast—This Is an Execution Problem
  • 🔒The CAN SLIM Check
  • 🔒Conclusion

Disclaimer: This report is for informational and educational purposes only and does not constitute investment advice. Always verify against primary filings before making any investment decision.

Continue Reading

This article is for pass holders.

Already a pass holder? Sign in · Continue with Google

Discover more from CANSLIM Research

Subscribe to get the latest posts sent to your email.

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.

Related Posts